Global whey powder prices were up 76% in June from a year earlier, according to a Rabobank agribusiness report, with spot prices 60% higher from the start of 2026. New Zealand dairy processors are expanding fractionation and bioactive capacity to capture the lift.

Yili Oceania, which owns Westland Milk Products, Oceania Dairy and related businesses, reported 2025 revenue of NZ$1.58 billion, up 14%. Pre-tax profit more than tripled to NZ$58.4 million, the group said in May 2026 results coverage.[[1]](https://www.rnz.co.nz/news/business/594672/yili-s-nz-profits-surge-as-shift-to-higher-value-dairy-pays-off)

The profit gain came even as the farmgate milk price Yili cited rose 30% to $10.16 per kilogram of milk solids. Executive director Zhiqiang Li linked the result to a faster shift into value-added products, capacity expansion and channel development.

Two demand waves are supporting whey and related proteins. Mainstream consumers are fortifying yoghurts, drinks and snacks. Patients on GLP-1 medicines such as Wegovy and Ozempic are urged to raise protein intake to limit lean-mass loss.

Protein boom — headline figures
Whey powder y/y (Jun)
+76%
spot +60% YTD 2026
Yili Oceania pre-tax profit
$58.4m
+3x vs 2024
Dairy exports YE Dec 2025
$24.3bn
+21% y/y
MPI dairy outlook YE Jun 2026
$28.6bn
+5%
Specialty whey strength sits alongside a large NZ dairy export base.
Source: Rabobank via trade coverage; Yili Oceania results; Stats NZ; MPI SOPI

Gallup reported in July 2026 that 11% of US adults currently take GLP-1 drugs for weight loss, up from 3% in 2024. A KFF poll in late 2025 put current use for any indication near one in eight adults. J.P. Morgan has sketched about 25 million Americans on therapy by 2030.[[2]](https://www.forbes.com/sites/zacharyfolk/2026/07/07/11-of-americans-now-take-glp-1-drugs-as-obesity-rate-declines-poll-finds/)

Clinical estimates cited in trade coverage put lean-muscle share of GLP-1 weight loss at 25–40% when protein and resistance training fall short. That clinical guidance has spilled into sports and medical nutrition demand for whey protein concentrate and isolate.

Whey is the liquid left after fat removal and casein separation in cheese and casein plants. Supply cannot jump overnight because it is co-produced with cheese. US and European trade prints in mid-2026 showed tight books and multi-year price spikes in higher concentrates.

The Guardian, citing DCA Market Intelligence, put north-west European food-grade whey powder near a record €1,700 a tonne in June 2026, up more than 50% year to date. Vesper data showed WPC 80% rising from about £4,300 a tonne in mid-2023 to more than £23,000 by mid-2026.[[3]](https://www.theguardian.com/business/2026/jun/09/fears-whey-protein-shortage-weight-loss-drugs-global-demand)

European WPC 80% price path
Concentrate prices tightened far faster than bulk powders over three years.
Source: Vesper data via The Guardian, June 2026